Cargando…
COVID-19 pandemic: a viewpoint from Asia
The expansion of severe acute respiratory syndrome (SARS) coronavirus 2 (SARSCoV-2) has now procured on epidemic percentages, affecting more than 190 nations in a matter of weeks. A widespread SARSCoV-2 contagion begun in Wuhan, Hubei Province, China, and circulate through China and beyond in Decemb...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256341/ https://www.ncbi.nlm.nih.gov/pubmed/32501384 http://dx.doi.org/10.1186/s42269-020-00337-5 |
_version_ | 1783539889582637056 |
---|---|
author | Abdullah-Al-Shafi, Md. |
author_facet | Abdullah-Al-Shafi, Md. |
author_sort | Abdullah-Al-Shafi, Md. |
collection | PubMed |
description | The expansion of severe acute respiratory syndrome (SARS) coronavirus 2 (SARSCoV-2) has now procured on epidemic percentages, affecting more than 190 nations in a matter of weeks. A widespread SARSCoV-2 contagion begun in Wuhan, Hubei Province, China, and circulate through China and beyond in December 2019. The containment events in China have lessened new instances by more than 90%, but this diminution is not the case to a different place. European countries like Italy and Spain have been the most affected. In Asia, the COVID-19 brings a catastrophe where after China mainland, countries like Iran and South Korea have been affected. There is now severe apprehension concerning the Asian health care system’s ability to effectually counter to the necessities of patients who are infected and need rigorous precaution for COVID-19. The patient’s ratio in special care reported in Iran has perpetually been between 6 and 8% who are rapidly infected. As about South Korea, the ratio is 3% and 4% who are rapidly infected. This analysis emphasizes the epidemiology of COVID-19, its effects in the Asia continent, and active case study of COVID-19 including the distinct countries. |
format | Online Article Text |
id | pubmed-7256341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-72563412020-05-29 COVID-19 pandemic: a viewpoint from Asia Abdullah-Al-Shafi, Md. Bull Natl Res Cent Review The expansion of severe acute respiratory syndrome (SARS) coronavirus 2 (SARSCoV-2) has now procured on epidemic percentages, affecting more than 190 nations in a matter of weeks. A widespread SARSCoV-2 contagion begun in Wuhan, Hubei Province, China, and circulate through China and beyond in December 2019. The containment events in China have lessened new instances by more than 90%, but this diminution is not the case to a different place. European countries like Italy and Spain have been the most affected. In Asia, the COVID-19 brings a catastrophe where after China mainland, countries like Iran and South Korea have been affected. There is now severe apprehension concerning the Asian health care system’s ability to effectually counter to the necessities of patients who are infected and need rigorous precaution for COVID-19. The patient’s ratio in special care reported in Iran has perpetually been between 6 and 8% who are rapidly infected. As about South Korea, the ratio is 3% and 4% who are rapidly infected. This analysis emphasizes the epidemiology of COVID-19, its effects in the Asia continent, and active case study of COVID-19 including the distinct countries. Springer Berlin Heidelberg 2020-05-29 2020 /pmc/articles/PMC7256341/ /pubmed/32501384 http://dx.doi.org/10.1186/s42269-020-00337-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Abdullah-Al-Shafi, Md. COVID-19 pandemic: a viewpoint from Asia |
title | COVID-19 pandemic: a viewpoint from Asia |
title_full | COVID-19 pandemic: a viewpoint from Asia |
title_fullStr | COVID-19 pandemic: a viewpoint from Asia |
title_full_unstemmed | COVID-19 pandemic: a viewpoint from Asia |
title_short | COVID-19 pandemic: a viewpoint from Asia |
title_sort | covid-19 pandemic: a viewpoint from asia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256341/ https://www.ncbi.nlm.nih.gov/pubmed/32501384 http://dx.doi.org/10.1186/s42269-020-00337-5 |
work_keys_str_mv | AT abdullahalshafimd covid19pandemicaviewpointfromasia |